Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Perphenazine from Actavis Pharma, Inc. (ANDA207582) to support the generic product's availabilit…
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals, Inc.'s supplemental application for Prochlorperazine Maleate.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Endo USA, Inc. to market Fluphenazine Decanoate, a long-acting injectable antipsychotic for schi…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for fluphenazine hydrochloride from Rising Pharma Holdings, Inc., under ANDA 218283.
-
FDA approval · 2025-01-22FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Clozapine submitted by Teva Pharmaceuticals USA, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-22FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for thioridazine hydrochloride submitted by Chartwell RX, LLC.
-
FDA approval · 2025-01-22FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for thioridazine hydrochloride, with Chartwell RX, LLC as the sponsor.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Fluphenazine hydrochloride submitted by Glenmark Pharmaceuticals Inc., USA.
-
FDA label_change · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental labeling application for HALOPERIDOL from Zydus Lifesciences Limited, updating the existing product labeling…
-
FDA approval · 2025-01-22FDA Approved: THIOTHIXENE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for thiothixene from ANI Pharmaceuticals, Inc., updating its labeling under the supplemental review.
-
FDA approval · 2025-01-22FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-Tab (risperidone) from Janssen Pharmaceuticals, Inc., updating the product under a s…
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
FDA approved a supplemental application for Perphenazine from Wilshire Pharmaceuticals, indicating an approved modification related to the d…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Fluphenazine hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application by Mylan Pharmaceuticals to market a generic fixed-dose combination of perphenazine and amitriptylin…
-
FDA approval · 2025-01-22FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for ARISTADA (aripiprazole lauroxil) from Alkermes, Inc.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for fluphenazine hydrochloride from Lannett Company, Inc., under the generic drug approval process.
-
FDA approval · 2025-01-22FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approves a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Dr. Reddys Laboratories Inc.)
FDA approved a supplemental application for Fluphenazine hydrochloride from Dr. Reddys Laboratories Inc., indicating a change to the approve…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Building Employment Skills Through Therapy for Veterans [NA]
This clinical trial update reports the completion of a VA-supported study evaluating therapy to build employment skills for veterans with sc…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Mylan Institutional LLC)
The FDA granted a supplemental approval for fluphenazine decanoate by Mylan Institutional LLC.
-
FDA approval · 2025-01-22FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for CLOZAPINE from Mylan Pharmaceuticals Inc. The action relates to a modification of the generi…
-
FDA approval · 2025-01-22FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., updating the generic product's status as an appr…
-
FDA label_change · 2025-01-22FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., indicating a label change to an existing product…
-
FDA label_change · 2025-01-22FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for thioridazine hydrochloride from Chartwell RX, LLC, likely updating labeling for this generic ant…
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for HALOPERIDOL submitted by Lannett Company, Inc., authorizing changes to the product's approva…